Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
epidural double lumen lidoderm scopolamine phenylepherene sciatica est pain control pregnancy intubationYour Article Summary
See Latest ArticlesMonoamine oxidase B inhibitors versus other dopaminergic agents in early Parkinson's disease
Cochrane Reviews, 10/09/09
Caslake R R et al. – Currently, there are several different treatments available for people with newly diagnosed Parkinson's including levodopa which is converted into dopamine in the brain, dopamine agonists which mimic the action of dopamine, and monoamine oxidase B (MAO–B) inhibitors (selegiline or rasagiline) which reduce the breakdown of dopamine in the brain. Each of these types of drugs has theoretical advantages and disadvantages. For example, although a very good treatment, levodopa can cause involuntary movements (dyskinesia), painful cramps (dystonia) and a shortened response to each dose (motor fluctuations) after a while, whilst MAO–B inhibitors and dopamine agonists may reduce the risk of these complications but are not so good at improving the symptoms of Parkinson's...Unfortunately the authors only identified two trials (593 patients) so there was only limited evidence. MAO–B inhibitors are one option for the early treatment of PD although they have weaker symptomatic effects than levodopa and dopamine agonists. They may reduce the rate of motor fluctuations compared with initial levodopa therapy and may have fewer significant adverse effects than the older agonists but data are too few to provide reliable conclusions.
Related Articles
Widely Used Cholesterol-lowering Drug May Prevent Progression Of Parkinsons Disease
ScienceDaily, 11/10/09
Relevance Score: 82%
What is Parkinsons Disease?
Internet Source, 11/09/09
Relevance Score: 81%
Novel agent for treatment of Parkinson's disease - Lu 02-750 - enters Lundbeck's development pipeline
Lundbeck, 11/02/09
Relevance Score: 81%
Widely used cholesterol-lowering drug may prevent progression
EurekAlert, 10/30/09
Relevance Score: 81%
The role of urate and xanthine oxidase in vascular oxidative stress: future directions
Therapeutics and Clinical Risk Management, 10/07/09
Relevance Score: 81%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Cardio-selective and non-selective beta-blockers in chronic obstructive pulmonary disease: effects on bronchodilator response and exercise
Internal Medicine Journal, 03/22/10
Oxycodone/acetaminophen at low dosage: An alternative pain treatment for patients with rheumatoid arthritis
Journal of Opioid Management, 03/22/10
Olanzapine versus other atypical antipsychotics for schizophrenia
Cochrane Reviews, 03/22/10
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Oxycodone/acetaminophen at low dosage: An alternative pain treatment for patients with rheumatoid arthritis
Journal of Opioid Management, 03/22/10
A review of the effect of anticonvulsant medications on bone mineral density and fracture risk
The American Journal of Geriatric Pharmacotherapy, 03/22/10
Today in Neurology...keeping you current
Receive free subspecialty "5-minute updates" via email
Primary Transcatheter Patent Foramen Ovale Closure Is Effective in Improving Migraine in Patients With High-Risk Anatomic and Functional Characteristics for Paradoxical Embolism
JACC - Journal of the American College of Cardiology: Cardiovascular Interventions, 03/22/10
Morphological Characteristics of Brain Tumors Causing Seizures
Archives of Neurology, 03/22/10
Today in Neurology...keeping you current
Receive free subspecialty "5-minute updates" via email
Morphological Characteristics of Brain Tumors Causing Seizures
Archives of Neurology, 03/22/10
Symptomatic Intracerebral Hemorrhage Among Eligible Warfarin-Treated Patients Receiving Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke
Archives of Neurology, 03/22/10
Locomotor and resistance training restore walking in an elderly person with a chronic incomplete spinal cord injury
NeuroRehabilitation, 03/22/10
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Treatment of Cluster Headache in Pregnancy and Lactation
Current Pain and Headache Reports, 03/22/10
Ranolazine-related dyspnea on exertion
The American Journal of Geriatric Pharmacotherapy, 03/22/10
Olanzapine versus other atypical antipsychotics for schizophrenia
Cochrane Reviews, 03/22/10
Today in Movement Disorders...keeping you current
Receive free subspecialty "5-minute updates" via email
Anxiety Affects Working Memory Only in Left Hemibody Onset Parkinson Disease Patients
Cognitive and Behavioral Neurology, 03/22/10
Familial associations of Alzheimer disease and essential tremor with Parkinson disease
European Journal of Neurology, 03/22/10
Carisbamate in essential tremor: Brief report of a proof of concept study
Movement Disorders, 03/22/10
Today in Neuro/Psych pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
(gamma)-Secretase as a Therapeutic Target in Alzheimer's Disease
Current Drug Targets, 03/22/10
Efficacy of Metformin and Topiramate in Prevention and Treatment of Second-Generation Antipsychotic-Induced Weight Gain
Annals of Pharmacotherapy, 03/22/10
Symptomatic Intracerebral Hemorrhage Among Eligible Warfarin-Treated Patients Receiving Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke
Archives of Neurology, 03/22/10
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Treatment of Cluster Headache in Pregnancy and Lactation
Current Pain and Headache Reports, 03/22/10
Weight Gain and Insulin Resistance in Children Treated With Valproate: The Influence of Time
Journal of Child Neurology, 03/22/10
Ranolazine-related dyspnea on exertion
The American Journal of Geriatric Pharmacotherapy, 03/22/10
Today in Neurology...keeping you current
Receive free subspecialty "5-minute updates" via email
Treatment of Cluster Headache in Pregnancy and Lactation
Current Pain and Headache Reports, 03/22/10
Weight Gain and Insulin Resistance in Children Treated With Valproate: The Influence of Time
Journal of Child Neurology, 03/22/10
Stroke maintenance exercise group: pilot study on daily functioning in long-term stroke survivors
The Australian Journal of Primary Health, 03/22/10
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
(gamma)-Secretase as a Therapeutic Target in Alzheimer's Disease
Current Drug Targets, 03/22/10
New Targets of Therapy in T-Cell Lymphomas
Current Drug Targets, 03/22/10
Medtronic Receives FDA Panels Unanimous Recommendation for Approval of Revo MRI(TM) SureScan(TM) Pacing System
Medtronic, 03/22/10
Today in Neurology...keeping you current
Receive free subspecialty "5-minute updates" via email
Morphological Characteristics of Brain Tumors Causing Seizures
Archives of Neurology, 03/22/10
Symptomatic Intracerebral Hemorrhage Among Eligible Warfarin-Treated Patients Receiving Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke
Archives of Neurology, 03/22/10
Locomotor and resistance training restore walking in an elderly person with a chronic incomplete spinal cord injury
NeuroRehabilitation, 03/22/10
Today in Neuro/Psych pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Olanzapine versus other atypical antipsychotics for schizophrenia
Cochrane Reviews, 03/22/10
Efficacy of Metformin and Topiramate in Prevention and Treatment of Second-Generation Antipsychotic-Induced Weight Gain
Annals of Pharmacotherapy, 03/22/10
(gamma)-Secretase as a Therapeutic Target in Alzheimer's Disease
Current Drug Targets, 03/22/10
Article Search
Sponsor